Please login to the form below

Not currently logged in
Email:
Password:

Communiqué Awards 2013: the finalists

Less than a month to go until the winners are revealed

Cx-Awards-evening

With just over three weeks to go before the Communiqué Awards 2013, it is time to reveal this year's crop of finalists.

Long before the excitement of the actual evening, the Communiqué Awards judges were hard at work spending hours poring over hundreds of submissions, debating the quality, originality and merits of each, before whittling down the entrants to a handful of finalists.

The standard of entries this year was once again high, and seems to be improving year on year, which made the selection process all the more challenging, but the names are in and are now posted on in the Communiqué Awards section of PMLiVE.

In each category there is an eclectic mix of finalists, covering a broad range of clients, therapy areas and initiatives. There is some truly innovative and novel work on display, along with some solid yet inspirational campaigns brilliantly executed.

In amongst the agencies and the in-house teams, we have seen surge in less traditional entrants, such as charities, which seems an excellent and encouraging reminder of the expanding stakeholder base within the healthcare communications industry.

So congratulations to all the finalists and fingers crossed - the winners will be revealed at the Awards ceremony, which will take place at London's Grosvenor House Hotel, Park Lane, on July 4, 2013 in recognition of the work undertaken by our industry to improve patient health.

And a big thank you to our judges who, without their hours of diligent assessment and probing debate, we would not be able to maintain the robust high standards the industry has come to expect from the Awards. 

10th June 2013

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ahair@onyxhealth.com

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...